Douglas J. Robertson, MD, MPH | VA Outcomes

Douglas J. Robertson, MD, MPH


Associate Professor, Geisel School of Medicine at Dartmouth
Chief, Gastroenterology, WRJ VA

Email


Research Interests

Dr. Robertson is a Gastroenterologist with research interests both in the epidemiology of colorectal cancer and the utility of screening and surveillance for this disease. He has used large data sets to understand the associations of factors (like drugs and diet) on the development of colorectal neoplasia. He also has studied the effectiveness of colonoscopy in the prevention of colorectal cancer in those with a prior history of neoplasia. Although colonoscopy is increasingly performed, his research suggests that the degree of cancer prevention afforded may not be as great as suggested by earlier studies.

He is past recipient of a VA HSR&D Career Development Award and has served as the Clinical Director of the Polyp Prevention Study Group that has performed large trials examining asprin, folate, calcium and Vitamin D on the prevention of polyps. Currently he is the National Co-Chair of VA Cooperative Study 577 CONFIRM trial. This randomized trial will directly compare up front screening colonoscopy to a strategy of annual stool testing with FIT for the prevention of colorectal cancer mortality in 50,000 US Veterans.


Selected Publications

  • Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41
  • Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85
  • Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136:832-41
  • Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer 2009;115:752-9
  • Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010;8:858-64
  • Robertson DJ, Riis AH, Friis S, Pedersen L, Baron JA, Sorensen HT. Neither long-term statin use nor atherosclerotic disease is associated with risk of colorectal cancer. Clin Gastroenterol Hepatol 2010;8:1056-61
  • Long MD, Lance T, Robertson D, Kahwati L, Kinsinger L, Fisher DA. Colorectal Cancer Testing in the National Veterans Health Administration. Digestive diseases and sciences 2011
  • Schmidt M, Johansen MB, Robertson DJ, et al. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Alimentary pharmacology & therapeutics 2012;35:165-74

Education and Training

Medical School University of Connecticut School of Medicine 1992
Residency University of Connecticut combined internal medicine residency (including Chief Medical Residency) 1996
Fellowship University of North Carolina at Chapel Hill 2000